MCL

Prof. Marek Trněný | ASH 2016 | Rituximab maintenance after ASCT: analysis of the Phase III trial of the Lysa/Goelams group (Abstract 145)

L:

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF